Skip to main content
. 2012 Jul;72(7):602–615. doi: 10.1055/s-0032-1315131

Fig. 1.

Fig. 1

 Tryphaena trial – median changes in the left ventricular ejection fraction (LVEF) of the treatment groups A–C (arm A: 3 × FEC + H + P followed by 3 × Doc + H + P; arm B: 3 × FEC followed by Doc + H + P; arm C: 6 × Docetaxel + Carboplatin + H + P) 30.